Anna Sutherland, palliative medicine doctor, looks at Cochrane evidence on the effectiveness and safety of mu-opioid antagonists for managing opioid-induced constipation in people with cancer and people receiving palliative care for whom laxatives have failed.
Anna Sutherland
Anna Sutherland, BSc, MBChB(Hons), MRCP (UK), PG Cert Med Ed, FHEA, has previously been a Cochrane UK Fellow and is currently an ST5 in Palliative Medicine. Anna has undertaken a Cochrane Review and established the Cochrane UK Trainee Advisory Committee (CUKI-TAG). Anna's main interest is in improving the quality of patient care at the end of life, with a particular interest in the evidence based use of emerging pharmacological therapies. Anna also enjoys spending time with her twin daughters and young son.
Author Archives: Anna Sutherland
There were twins in a bed and Cochrane said “no difference…”
Should premature twins be looked after in one cot in the neonatal nursery? Anna Sutherland blogs her own experience and Cochrane evidence
Hospital at Home Increases the Chances of Dying at Home
It’s Dying Matters Awareness Week, an opportunity to place the importance of talking about dying, death and bereavement on...